NCT07219251 Engagement of Veterans With Lung Cancer
| NCT ID | NCT07219251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Palo Alto Veterans Institute for Research |
| Condition | Lung Cancer (NSCLC) |
| Study Type | INTERVENTIONAL |
| Enrollment | 194 participants |
| Start Date | 2026-02-27 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 194 participants in total. It began in 2026-02-27 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.
Eligibility Criteria
Inclusion Criteria: 1. Veteran patients with diagnosis of any stage of lung cancer; 2. 18 years of age or older; 3. English- or Spanish-speaking; 4. can self-administer questionnaires in English or Spanish; 5. valid telephone number; 6. receiving oncology care at participating sites; 7. currently newly diagnosed or receiving or having completed systemic anti-cancer therapy and/or radiation therapy within 12 months, defined as oral, injection, or intravenous therapy (chemotherapy, targeted therapy, or immunotherapy) Exclusion Criteria: 1. no capacity to consent; 2. actively receiving hospice care
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07219251 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer (NSCLC). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07219251 currently recruiting?
Yes, NCT07219251 is actively recruiting participants. Contact the research team at manalip@stanford.edu for enrollment information.
Where is the NCT07219251 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT07219251 clinical trial?
NCT07219251 is sponsored by Palo Alto Veterans Institute for Research. The trial plans to enroll 194 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.